AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
IMPACT OF DISEASE-ACTIVITY AND CUMULATIVE DAMAGE ON THE HEALTH OF LUPUS PATIENTS
Authors: FORTIN PR ABRAHAMOWICZ M NEVILLE C DUBERGER R FRAENKEL L CLARKE AE DANOFF D
Citation: Pr. Fortin et al., IMPACT OF DISEASE-ACTIVITY AND CUMULATIVE DAMAGE ON THE HEALTH OF LUPUS PATIENTS, Lupus, 7(2), 1998, pp. 101-107
PSYCHOSOCIAL CONTRIBUTORS TO MENTAL AND PHYSICAL HEALTH IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: DOBKIN PL FORTIN PR JOSEPH L ESDAILE JM DANOFF DS CLARKE AE
Citation: Pl. Dobkin et al., PSYCHOSOCIAL CONTRIBUTORS TO MENTAL AND PHYSICAL HEALTH IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis care and research, 11(1), 1998, pp. 23-31
PREDICTORS OF DELAY IN STARTING RADIATION TREATMENT FOR PATIENTS WITHEARLY-STAGE BREAST-CANCER
Authors: BENK V HO V FORTIN PR ZHANG G LEVINTON C FREEMAN CR
Citation: V. Benk et al., PREDICTORS OF DELAY IN STARTING RADIATION TREATMENT FOR PATIENTS WITHEARLY-STAGE BREAST-CANCER, International journal of radiation oncology, biology, physics, 41(1), 1998, pp. 109-115
THE RELATIONSHIP BETWEEN DISEASE-ACTIVITY AND EXPERT PHYSICIANS DECISION TO START MAJOR TREATMENT IN ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS - A DECISION AID FOR DEVELOPMENT OF ENTRY CRITERIA FOR CLINICAL-TRIALS
Authors: ABRAHAMOWICZ M FORTIN PR DUBERGER R NAYAK V NEVILLE C LIANG MH
Citation: M. Abrahamowicz et al., THE RELATIONSHIP BETWEEN DISEASE-ACTIVITY AND EXPERT PHYSICIANS DECISION TO START MAJOR TREATMENT IN ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS - A DECISION AID FOR DEVELOPMENT OF ENTRY CRITERIA FOR CLINICAL-TRIALS, Journal of rheumatology, 25(2), 1998, pp. 277-284
COMPREHENSIVE RADIOGRAPHIC EVALUATION OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS - DEVELOPMENT AND INTERRATER RELIABILITY OF A SCORING SYSTEM
Authors: MATA S CHHEM RK FORTIN PR JOSEPH L ESDAILE JM
Citation: S. Mata et al., COMPREHENSIVE RADIOGRAPHIC EVALUATION OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS - DEVELOPMENT AND INTERRATER RELIABILITY OF A SCORING SYSTEM, Seminars in arthritis and rheumatism, 28(2), 1998, pp. 88-96
SOCIAL SUPPORT AND HEALTH-STATUS INFLUENCE SATISFACTION WITH MEDICAL-CARE AMONG PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: DACOSTA D CLARKE AE DOBKIN PL SENECAL JL GOULET JR CHOQUETTE D GRODZICKY T FORTIN PR DANOFF DS ESDAILE JM
Citation: D. Dacosta et al., SOCIAL SUPPORT AND HEALTH-STATUS INFLUENCE SATISFACTION WITH MEDICAL-CARE AMONG PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Psychosomatic medicine, 60(1), 1998, pp. 130-131
THE USE OF ALTERNATIVE MEDICAL THERAPIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
Authors: MOORE A PETRI MA MANZI S ISENBERG DA GORDON C SENECAL JL STPIERRE Y FORTIN PR SUTCLIFFE N GOUTET JR CHOQUETTE D GRODZICKY T ESDAILE JM CLARKE AE
Citation: A. Moore et al., THE USE OF ALTERNATIVE MEDICAL THERAPIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 41(9), 1998, pp. 605-605
RATES AND PREDICTORS OF LUPUS FLARES
Authors: FORTIN PR FERLAND D MOORE AD BELISLE P JOSEPH L CLARKE AE
Citation: Pr. Fortin et al., RATES AND PREDICTORS OF LUPUS FLARES, Arthritis and rheumatism, 41(9), 1998, pp. 1114-1114
UNDERESTIMATING THE VALUE OF RHEUMATIC DISEASES - ASSESSING THE INDIRECT COSTS OF WOMEN WITH LUPUS (SLE)
Authors: STPIERRE Y PENROD J PETRI M MANZI S ISENBERG DA GORDON C SENECAL JL JOSEPH L FORTIN PR SUTCLIFFE N GOULET JR CHOQUETTE D GRODZICKY T ESDAILE JM CLARKE AE
Citation: Y. Stpierre et al., UNDERESTIMATING THE VALUE OF RHEUMATIC DISEASES - ASSESSING THE INDIRECT COSTS OF WOMEN WITH LUPUS (SLE), Arthritis and rheumatism, 41(9), 1998, pp. 1131-1131
AN INTERNATIONAL COMPARISON OF HEALTH COSTS AND CHANGE IN HEALTH-STATUS (HS) IN SLE
Authors: CLARKE AE PETRI M MANZI S ISENBERG DA GORDON C SENECAL JL STPIERRE Y JOSEPH L PENROD J FORTIN PR SUTCLIFFE N GOULET JR CHOQUETTE D GRODZICKY T ESDAILE JM
Citation: Ae. Clarke et al., AN INTERNATIONAL COMPARISON OF HEALTH COSTS AND CHANGE IN HEALTH-STATUS (HS) IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1143-1143
PREDICTING HEALTH-CARE UTILIZATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - COUNTRY OF CARE, DISEASE DAMAGE AND HEALTH-STATUS
Authors: CLARKE AE PETRI M MANZI S ISENBERG DA GORDON C SENECAL JL STPIERRE Y JOSEPH L PENROD J FORTIN PR SUTCLIFFE N GOULET JR CHOQUETTE D GRODZICKY T ESDAILE JM
Citation: Ae. Clarke et al., PREDICTING HEALTH-CARE UTILIZATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - COUNTRY OF CARE, DISEASE DAMAGE AND HEALTH-STATUS, Arthritis and rheumatism, 41(9), 1998, pp. 1144-1144
THE DIRECT COSTS OF A FLARE IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
Authors: MOORE A FERLAND D CLARKE AE BELISLE P STPIERRE Y JOSEPH L PENROD J FORTIN PR
Citation: A. Moore et al., THE DIRECT COSTS OF A FLARE IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 41(9), 1998, pp. 1174-1174
VIEWPOINT - RESPONSE CRITERIA FOR CLINICAL-TRIALS IN SYSTEMIC LUPUS ERYTHEMATOSUS. (VOL 4, PG 336, 1995)
Authors: LIANG MH FORTIN PR
Citation: Mh. Liang et Pr. Fortin, VIEWPOINT - RESPONSE CRITERIA FOR CLINICAL-TRIALS IN SYSTEMIC LUPUS ERYTHEMATOSUS. (VOL 4, PG 336, 1995), Lupus, 6(7), 1997, pp. 619-619
INHIBITION OF LUPUS ANTICOAGULANT ACTIVITY BY HEXAGONAL (II) PHOSPHATIDYLETHANOLAMINE REQUIRES A PLASMA COFACTOR
Authors: RAUCH J TANNENBAUM M FORTIN PR
Citation: J. Rauch et al., INHIBITION OF LUPUS ANTICOAGULANT ACTIVITY BY HEXAGONAL (II) PHOSPHATIDYLETHANOLAMINE REQUIRES A PLASMA COFACTOR, Thrombosis and haemostasis, 1997, pp. 1367-1367
AGE-IGG AN AUTO ANTIGEN IN RHEUMATOID-ARTHRITIS ASSOCIATED WITH SEVERE DISEASE
Authors: NEWKIRK MM FORTIN PR
Citation: Mm. Newkirk et Pr. Fortin, AGE-IGG AN AUTO ANTIGEN IN RHEUMATOID-ARTHRITIS ASSOCIATED WITH SEVERE DISEASE, Journal of allergy and clinical immunology, 99(1), 1997, pp. 775-775
PSYCHOSOCIAL CONTRIBUTORS TO MENTAL AND PHYSICAL HEALTH IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: DOBKIN PL CLARKE AE FORTIN PR JOSEPH L DANOFF DA
Citation: Pl. Dobkin et al., PSYCHOSOCIAL CONTRIBUTORS TO MENTAL AND PHYSICAL HEALTH IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Psychosomatic medicine, 59(1), 1997, pp. 84-85
A CONTROLLED-STUDY OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS - CLINICAL-FEATURES AND FUNCTIONAL STATUS
Authors: MATA S FORTIN PR FITZCHARLES MA STARR MR JOSEPH L WATTS CS GORE B ROSENBERG E CHHEM RK ESDAILE JM
Citation: S. Mata et al., A CONTROLLED-STUDY OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS - CLINICAL-FEATURES AND FUNCTIONAL STATUS, Medicine, 76(2), 1997, pp. 104-117
HIGH PREVALENCE OF ACQUIRED ACTIVATED PROTEIN-C RESISTANCE IN A LARGEKINDRED WITH AUTOIMMUNE-DISEASE
Authors: KASSIS J HUDSON N RAUCH J BUSQUE L MATA S FERLAND D FORTIN PR
Citation: J. Kassis et al., HIGH PREVALENCE OF ACQUIRED ACTIVATED PROTEIN-C RESISTANCE IN A LARGEKINDRED WITH AUTOIMMUNE-DISEASE, Blood, 90(10), 1997, pp. 1771-1771
INHIBITION OF LUPUS ANTICOAGULANT ACTIVITY BY HEXAGONAL(II) PHASE PHOSPHATIDYLETHANOLAMINE REQUIRES PROTHROMBIN AS A COFACTOR
Authors: RAUCH J TANNENBAUM M FORTIN PR
Citation: J. Rauch et al., INHIBITION OF LUPUS ANTICOAGULANT ACTIVITY BY HEXAGONAL(II) PHASE PHOSPHATIDYLETHANOLAMINE REQUIRES PROTHROMBIN AS A COFACTOR, Arthritis and rheumatism, 40(9), 1997, pp. 445-445
LEARNING FROM DISCORDANCE IN PATIENT AND PHYSICIAN GLOBAL ASSESSMENTSOF LUPUS DISEASE-ACTIVITY
Authors: NEVILLE C JOSEPH L CLARKE AE BELISLE P FERLAND D FORTIN PR
Citation: C. Neville et al., LEARNING FROM DISCORDANCE IN PATIENT AND PHYSICIAN GLOBAL ASSESSMENTSOF LUPUS DISEASE-ACTIVITY, Arthritis and rheumatism, 40(9), 1997, pp. 845-845
ACTIVITY AND DAMAGE PREDICTS LATER FLARES IN LUPUS
Authors: FORTIN PR FERLAND D CLARKE AE BELISLE P JOSEPH I
Citation: Pr. Fortin et al., ACTIVITY AND DAMAGE PREDICTS LATER FLARES IN LUPUS, Arthritis and rheumatism, 40(9), 1997, pp. 1060-1060
FAMILIAL ANTIPHOSPHOLIPID ANTIBODY SYNDROME - CLINICAL MANIFESTATIONSAND COAGULATION ABNORMALITIES
Authors: HUDSON N KASSIS J RAUCH J BUSQUE L MATA S FERLAND D FORTIN PR
Citation: N. Hudson et al., FAMILIAL ANTIPHOSPHOLIPID ANTIBODY SYNDROME - CLINICAL MANIFESTATIONSAND COAGULATION ABNORMALITIES, Arthritis and rheumatism, 40(9), 1997, pp. 1609-1609
AN INTERNATIONAL COMPARISON OF HEALTH-STATUS AND SATISFACTION FOR PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
Authors: CLARKE AE PETRI M MANZI S ISENBERG D GORDON C SENECAL JL SUTCLIFF N CHOQUETTE D GOULET JR GRODZICKY T FORTIN PR DANOFF DS LEVINTON C PANARITIS D ESDAILE JM
Citation: Ae. Clarke et al., AN INTERNATIONAL COMPARISON OF HEALTH-STATUS AND SATISFACTION FOR PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 40(9), 1997, pp. 1670-1670
AN INTERNATIONAL COMPARISON OF HEALTH RESOURCE UTILIZATION FOR PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
Authors: CLARKE AE PETRI M MANZI S ISENBERG D GORDON C SENECAL JL SUTCLIFF N CHOQUETTE D GOULET JR GRODZICKY T FORTIN PR DANOFF DS LEVINTON C STPIERRE Y HO V ESDAILE JM
Citation: Ae. Clarke et al., AN INTERNATIONAL COMPARISON OF HEALTH RESOURCE UTILIZATION FOR PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 40(9), 1997, pp. 1711-1711
FAMILIAL ANTIPHOSPHOLIPID SYNDROME AND HLA-DRB GENE ASSOCIATIONS
Authors: HUDSON N BUSQUE L RAUCH J KASSIS J FORTIN PR
Citation: N. Hudson et al., FAMILIAL ANTIPHOSPHOLIPID SYNDROME AND HLA-DRB GENE ASSOCIATIONS, Arthritis and rheumatism, 40(10), 1997, pp. 1907-1908
Risultati: 1-25 | 26-42